BETA

4 Amendments of Mercedes BRESSO related to 2017/0328(COD)

Amendment 7 #
Proposal for a regulation
Recital 1
(1) In the context of the United Kingdom's notification on 29 March 2017 of its intention to leave the Union, pursuant to Article 50 of the Treaty on European Union, the other 27 Member States, meeting in the margins of the General Affairs Council (‘Article 50’), selected Amsterdam, the Netherlands, as the new seat of the European Medicines Agency. on the basis of information requiring further verification of the actual availability of the premises selected as well as of the accessibility of those premises’ facilities;
2018/02/21
Committee: AFCO
Amendment 8 #
Proposal for a regulation
Article 1 – paragraph 1
Regulation (EC) No 726/2004
Article 71a – paragraph 1
The Agency shall have its seat in Amsterdam, the NetherlandIn order to respect fully the prerogatives of the European Parliament, the decision on the location of the Agency needs, and legally must, be taken under the ordinary legislative procedure, pursuant to which the European Parliament and the Council are equal co-legislators.
2018/02/21
Committee: AFCO
Amendment 44 #
Proposal for a regulation
Article 1 – paragraph 1
Regulation (EC) No 726/2004
Article 71a
The seat of the Agency shall have its seat in Amsterdam, the Netherlands. be located in a city of a European Union Member State on the basis of absolute assurance that: - it meets, without any exception or limitation, as from January 2019, all requirements, conditions and criteria necessary to ensure that the Agency can function effectively; - it ensures the full and immediate operational continuity of the Agency’s activities, which are highly important to society and of great scientific value. The Agency's remit shall relate to what is recognised as a fundamental right of European citizens to health protection. Its headquarters shall be selected under the ordinary legislative procedure pursuant to Articles 114 and 168(4)(b) TFEU.
2018/01/31
Committee: ENVI